The global electrosurgical analyzer market size is projected to be valued at US$ 3.6 Billion in 2022 and US$ 6.4 Billion in 2032. It is set to showcase a considerable CAGR of 3.9% in the forecast period from 2022 to 2032. The high demand for minimally invasive surgeries and ongoing technological advancements in the field of electrosurgical instruments are anticipated to propel the sales of electrosurgical analyzers in the upcoming years.
Report Attribute | Details |
Electrosurgical Analyzer Market Estimated Base Year Value (2021) | US$ 2.1 Billion |
Electrosurgical Analyzer Market Expected Market Value (2022) | US$ 3.6 Billion |
Electrosurgical Analyzer Market Anticipated Forecast Value (2032) | US$ 6.4 Billion |
Electrosurgical Analyzer Market Projected Growth Rate (2022-2032) | 3.9% CAGR |
Electrosurgical analyzers are extensively used to maintain and evaluate critical Electrosurgical Unit (ESU) functions, such as crest factor, voltage, frequency, load resistance, precision power, and measurement of energy. These are compatible with both isolated and ground types of ESUs.
The increasing usage of these analyzers in the testing of low-level bipolar and high-level monopolar ESU outputs is anticipated to propel the market. The urgent need to determine the safety and performance of electrosurgery generators is another factor that is likely to bolster the growth.
The rising investment by key players in the development of unique medical and pharmaceutical equipment for ensuring patients’ safety is estimated to augur well for the market. Apart from that, the increasing focus of key players on the improvement of these analyzers to provide better optimal performance is set to positively influence the market.
The surging demand for electrosurgical analyzers in the healthcare industry to ensure the safety of doctors and patients during the usage of ESU is also anticipated to drive the market. Many government organizations are expected to implement stringent norms on the correct usage of these analyzers, which is anticipated to aid the growth.
The increasing number of age-related, cosmetic, and medical surgeries performed across the globe is projected to boost the demand for electrosurgical analyzers in the near future. As per the American Society of Plastic Surgeons, in 2020, around 352,555 nose reshaping, 193,073 breast augmentation, 211,067 liposuction, and 325,112 eyelid surgeries were performed in the U.S. alone. These numbers are estimated to surge in the evaluation period, thereby driving the market.
Besides, the increasing funding provided by the federal government is set to push the market. The rapid expansion of the healthcare industry owing to the contributions of both private and public players in emerging economies is another vital factor that is set to augment the market.
Patients with Implantable Cardioverter Defibrillators (ICDs), gastric and cardiac pacemaker, as well as cochlear implants are not recommended to undergo electrosurgery. This factor may hinder the sales of electrosurgical analyzers in the near future. In addition to that, risks associated with electrosurgical procedures, such as peritonitis, organ damage, perforation, and vessel hemorrhage may obstruct the growth in this market.
The surging prevalence of chronic and acute infections and diseases in developed countries, such as Canada and the U.S. is anticipated to augur well for the North America electrosurgical analyzer market growth in the assessment period. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 adults have a chronic disease in the U.S., whereas 4 in 10 adults have two or more diseases. This trend is set to continue throughout the forthcoming years, thereby bolstering the regional market.
The increasing aging population, presence of a well-developed healthcare infrastructure, and the entry of various prominent companies across North America are likely to drive the market. The rising prevalence of chronic diseases associated with the heart and kidneys among people is another crucial factor that is estimated to spur the market.
Asia Pacific is estimated to remain in the second position, followed by North America in terms of the electrosurgical analyzer market share. The rising prevalence of colorectal cancer is set to compel people to incline towards electro surgeries in this region.
As per the World Health Organization (WHO), in 2020, around 10 million deaths occurred due to cancer across the globe. It further mentions that cancer-causing infections, including hepatitis and Human Papillomavirus (HPV) are mainly responsible for nearly 30% of cancer cases in middle- and low-income countries. Thus, the surging number of cancer patients in China and India is likely to boost the market.
Some of the renowned companies present in the global electrosurgical analyzer market are Olympus, Fluke Biomedical, Smith Nephew, Rigel Medical, Medtronic, and B. Braun among others.
Most of the reputed players in the market are focusing on signing agreements and product launches to ensure future growth and sustain their leadership. They are also engaging in the development of cost-effective equipment and geographic expansions to provide high-quality products to people in developing countries. Meanwhile, a few other key players are striving to strengthen their portfolios by entering into mergers and acquisitions.
Report Attribute | Details |
Growth Rate | CAGR of 3.9% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2015-2020 |
Forecast Period | 2022-2032 |
Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
By Product Type:
By Application:
By Region:
The global electrosurgical analyzer market is expected to exceed US$ 6.4 Billion by 2032.
North America is predicted to be the fastest expanding market for electrosurgical analyzers.
Olympus, Fluke Biomedical, Smith Nephew, Rigel Medical, Medtronic, and B. Braun are some of the leading electrosurgical analyzer manufacturers.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.